Literature DB >> 20076812

Irritable bowel syndrome: a population based study.

Babak Khoshkrood-Mansoori1, Mohamad Amin Pourhoseingholi, Azadeh Safaee, Bijan Moghimi-Dehkordi, Babk Sedigh-Tonekaboni, Asma Pourhoseingholi, Manijeh Habibi, Mohamad Reza Zali.   

Abstract

BACKGROUND: The prevalence of irritable bowel syndrome (IBS) is relatively high, but up to now, no population based study in Iran has used the ROME III criteria. The aim of the present study was to determine the prevalence of IBS by using the ROME III criteria in the adult population of Iran.
METHODS: A face to face survey was conducted in a large area of the Tehran province. IBS was diagnosed by using a validated questionnaire based on the ROME III criteria.
RESULTS: The study population comprised 18,180 participants, with a female to male ratio of 1. 15.3% of participants complained of gastrointestinal (GI) symptoms, while the prevalence of IBS was estimated to be 1.1% (139 women, 59 men, p=0.000). IBS patients were more likely to be married, and older. The most common presenting symptoms of IBS were abdominal pain that was relieved by defecation (94%), change in fecal consistency (78%), and change in bowel frequency (70%). Constipation was predominant in 52% of IBS cases, diarrhea was predominant in 18%, and 8% experienced intermittent diarrhea and constipation.
CONCLUSION: The prevalence of IBS is relatively low in the Iranian adult population according to the ROME III criteria. The most probable reasons are the specificity of ROME III criteria and the characteristic low prevalence of GI symptoms in the study population.

Entities:  

Mesh:

Year:  2009        PMID: 20076812

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  28 in total

Review 1.  Lubiprostone in constipation: clinical evidence and place in therapy.

Authors:  Nicholas Wilson; Ron Schey
Journal:  Ther Adv Chronic Dis       Date:  2015-03       Impact factor: 5.091

2.  Direct and indirect medical costs of functional constipation: a population-based study.

Authors:  Hamid Mohaghegh Shalmani; Hamid Soori; Babak Khoshkrood Mansoori; Mohsen Vahedi; Bijan Moghimi-Dehkordi; Mohammad Amin Pourhoseingholi; Mohsen Norouzinia; Mohammad Reza Zali
Journal:  Int J Colorectal Dis       Date:  2010-10-19       Impact factor: 2.571

3.  Gender Role in Irritable Bowel Syndrome: A Comparison of Irritable Bowel Syndrome Module (ROME III) Between Male and Female Patients.

Authors:  Sanam Javid Anbardan; Nasser Ebrahimi Daryani; Seyed-Mohammad Fereshtehnejad; Sahar Taba Taba Vakili; Mohammad Reza Keramati; Hossein Ajdarkosh
Journal:  J Neurogastroenterol Motil       Date:  2012-01-16       Impact factor: 4.924

Review 4.  Global burden of irritable bowel syndrome: trends, predictions and risk factors.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-15       Impact factor: 46.802

5.  The current prevalence of irritable bowel syndrome in Asia.

Authors:  Full-Young Chang; Ching-Liang Lu; Tseng-Shing Chen
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

6.  Comparison of long-term effects of cognitive-behavioral therapy versus mindfulness-based therapy on reduction of symptoms among patients suffering from irritable bowel syndrome.

Authors:  Saeedeh Zomorodi; Saeed Abdi; Seyed Kazem Rasulzadeh Tabatabaee
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2014

7.  Evaluation of psychological aspects among subtypes of irritable bowel syndrome.

Authors:  Neda Farzaneh; Mehdi Ghobakhlou; Bijan Moghimi-Dehkordi; Nosrotollah Naderi; Farbod Fadai
Journal:  Indian J Psychol Med       Date:  2012-04

8.  Prevalence of irritable bowel syndrome: a community based study from northern India.

Authors:  Govind K Makharia; Anil K Verma; Ritvik Amarchand; Anil Goswami; Prashant Singh; Abhishek Agnihotri; Faizul Suhail; Anand Krishnan
Journal:  J Neurogastroenterol Motil       Date:  2011-01-26       Impact factor: 4.924

9.  Bloating in Iran: SEPAHAN Systematic Review No. 4.

Authors:  Parnaz Daneshpajouhnejad; Ammar Hassanzadeh Keshteli; Shirin Sadeghpour; Samaneh Khanpour Ardestani; Peyman Adibi
Journal:  Int J Prev Med       Date:  2012-03

10.  Irritable Bowel Syndrome in Iran: SEPAHAN Systematic Review No. 1.

Authors:  Pegah Jahangiri; Marsa Sadat Hashemi Jazi; Ammar Hassanzadeh Keshteli; Shirin Sadeghpour; Ehssan Amini; Peyman Adibi
Journal:  Int J Prev Med       Date:  2012-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.